Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the transporters of serotonin and dopamine in ALS
patients in relation with the clinical phenotype, i.e., patients without stiffness, patients
with pyramidal stiffness, patients with mixed (pyramidal and extra pyramidal) stiffness.
For such a goal the investigators will use SPECT to compare the binding of two specific
tracers in ALS patients and in matched healthy controls.
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborators:
Agence Générale des Equipements et Produits de Santé ARS (Association pour la Recherche sur la Sclérose Latérale Amyotrophique) Association Française contre les Myopathies (AFM), Paris